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SUMMARY
Tumours of non-endocrine organs may cause endocrine
syndromes through the production of 'ectopic' hormones.
Ectopic corticotrophin was probably responsible for the
first published cases, and the clinical condition related
to this hormone is described. It can be mimicked by ecto-
pically-produced corticotrophin-releasing hormone.
Tumorous hypercalcaemia is usually caused by an
ectopic parathyroid hormone-like substance, while in-
appropriate antidiuresis may be due to an ectopic anti-
diuretic hormone. Hyperthyroidism can be induced by a
thyroid-stimulating hormone derived from trophoblastic
tumours, which probably differs from normal placental
TSH.
The possible mechanisms underlying these phenomena
are 'de-repression' (most likely) and total breakdown of
the genetic code in the tumour cells.
S. Atr. Med. J., 48, 347 (1974).
Cancer can do many strange things. Tumours of non-
endocrine organs may cause endocrine syndromes, due to
the cancer cells assuming the ability to synthesise poly-
peptides that are either identical with normal hormones
or can exactly mimic their effects. These are the 'ectopic'
hormones.
What follows is no exhaustive review of the situation,'"
but rather an attempt to highlight some of the conditions
that may be of particular interest to surgeons and others.
Ectopic Corticotrophin (ACTH) Production'
In 1928 Brown' described the condition he called 'diabetes
of bearded women', in association with oat-cell carcinoma
of the bronchus, and in 1931 Leyton and co-workers·
described 2 cases of Cushing's syndrome with epithelial
tumours of the thymus, but the relationship between
tumour and syndrome remained obscure for many years.
Cushing himself did not describe his own syndrome until
1932.
The main tumours responsible for ectopic ACTH pro-
duction are: bronchus (oat-cell); carcinoid of gastro-
intestinal tract and bronchus; thymus (epithelial cell');
thyroid (medullary carcinoma); pancreatic islets; phaeo-
chromocytoma; also parotid, parathyroid, stomach, gall
bladder, kidney, colon, prostate, ovary, testis, breast,
trachea.
It has been suggested" that all ACTH-producing cells
share certain common histochemical, cytological and ultra-
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structural properties and may even have a common
embryological origin-the neural crest.
Unlike primary Cushing's disease, the ectopic ACTH
syndrome is more common among males and presents
with muscular weakness and wasting with marked hypo-
kalaemic alkalosis, rather than the typical appearance of
Cushing's syndrome. Hyperglycaemia, oedema and pig-
mentation are frequent, the latter being due to conco-
mitant ectopic production of beta-MSH, a closelv related
polypeptide. Deterioration is rapid, but successful treat-





Fig. 1. Nonnal 'bypotbalamic-pituitary-adrenal axis. See
text.
The normal hypothalamic-pituitary-adrenal axis is
depicted in Fig. 1. The hypothalamus secretes the cortico-
trophin-releasing hormone (or factor) (CRH or CRF) which
stimulates the pituitary to release ACTH, which in turn
initiates the chemical pathway in the adrenals leading to
formation of cortisol and other steroids. Cortisol controls
the feedback mechanism by inhibiting the hypothalamic
production of CRH and so indirectly controls its own
levels. Synthetic corticosteroids (e.g. dexamethasone, DMZ)
will also inhibit CRH and ACTH production, while 'stress'
situations stimulate them.
With ectopic hormone formation, large amounts of
ACTH-like substances are produced which give rise to
348 S.-A. MEDIESE TYDSKRIF 23 Februarie 1974
Hypercalcaemia, Ectopic PTH-Like Hormone"
Fig. 3. Cancer of 'bronchus producing CRH. The patient's
own pituitary gland now releases excessive ACI'H. See
text.
Fig. 2. Cancer of bronchus producing ACfH-like sub-
stance and MSH. Adrenal hyperplasia, massive amounts
of cortisol, pituitary suppression. No effect of dexametha-
sone or metyrapone.
HYPERCALCAEMIA FROM TUMOURS
Hypercalcaemia in relation to tumours is most common
in cases of breast cancer with bony metastases and here
it is presumably caused by simple dissolution of bone
salt (Fig. 4). In this condition one would logically expect
the serum phosphorus to be high, since this element is
also driven into the bloodstream from the skeleton, and
indeed it usually is; but not always, as we shall see.
Fig. 4. Theoretical possibilities include: (i) bone destruc-
tion by melastases; (ii) production of PTH and vitamin





EJ-. PTH estructiontumOur·", ...·PTHu~Serum Ca++
~Vit.D~
Inappropriate Antidiuretic Hormone"
In the case of other tumours the serum calcium level
may be raised without any direct skeletal involvement.
Here the serum phosphorus level is usually low and the
syndrome is due to an ectopic parathyroid hormone-like
hormone. Tumours responsible are: bronchus (squamous-
cell)-most commonly; kidney-next commonest; pancreas,
parotid, adrenals, hepatoma, colon, spleen, penis, lym-
phoma, leukaemia, sarcoma, breast (one single case, with
secondaries in liver).
Ectopic hormone hypercalcaemia may be difficult to
distinguish from primary hyperparathyroidism. It is com-
mon in males who are clinically ill with a short history
and without either stones or bone disease. The serum
calcium level may be very high. The alkaline phosphatase
may be raised in some cases without bone involvement,
which does not happen in hyperparathyroidism. In some
cases the hypercalcaemia responds to cortisone. The two
conditions may coexist
The syndrome of inappropriate antidiuresis, due to
ectopic ADH, occurs most commonly with bronchial car-
cinoma (oat-cell), and has also been reported in cases of
cerebellar haemangioblastoma, pituitary chromophobe
adenoma, pancreatic neoplasm, lymphoma and duodenal
tumour.
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bilateral adrenal hyperplasia and tremendous overproduc-
tion of cortisol, which cannot be suppressed by dexa-
methasone (Fig. 2).
The hypothalamic-releasing hormones are also simple
polypeptides, so it is not surprising that CRH-like sub-
stances can also be produced by cancer cells, leading to
the same clinical syndrome, but now with ectopically-
provoked overactivity of the pituitary and overproduction
of normal pituitary ACTH (Fig. 3). Tumours responsible
have arisen in the bronchus' and pancreas. In this situation
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Clinically, overhydration leads to somnolence, irritability,
confusion and disorientation. Dilutional hyponatraemia is
present with low serum sodium and chloride levels
together with a concentrated urine. The plasma volume is
normal or raised and the haematocrit normal or low.
Glomerular filtration rate and adrenal function are normal
(otherwise the diagnosis is extremely difficult).
The mechanism of production of this syndrome is incom-
pletely understood. ADH increases distal tubular reabsorp-
tion of water, leading to water retention which increases
the circulating blood volume and this causes simple
dilutional . hyponatraemia. One might expect the hypo-
natraemia to stimulate aldosterone release with consequent
oedema, but this does not occur. The logical treatment is
therefore restriction of fluid intake.
Hyperthyroidism, TSH Production"
The tumours involved are trophoblastic-choriocar-
cinoma and hydatidiform mole; also carcinoma (em-
bryoma) of testis; it is doubtful whether tumours at any
other site have been responsible for hyperthyroidism,"
though some (e.g. bronchus) may be capable of producing
a TSH.
Clinicallv there are no eye signs, perhaps because there
is no exce~s of the long-acting thyroid stimulator (LATS),
and little or no goitre. The usual thyroid function tests are
similar to those in Grave's disease, but complete remission
occurs on control of the primary tumour.
The hormone production in this syndrome should not,
strictly speaking, be called 'ectopic', because the normal
placenta produces TSH. The two polypeptides are, however,
not identical, tumour TSH being a larger molecule with
immunological differences. It may represent a specific
fetal protein. _
Other syndromes related to ectopil: hormone production
include:
'Typical' carcinoid syndrome (5-hydroxytryptamine
serotonin)-midgut tumours.
'Atypical' carcinoid syndrome (5-hydroxytryptophan +
histamine)-foregut derivatives (e.g. bronchus).
Erythrocytosis (erythropoietin)-<:erebellar haemangio-
blastoma, hepatoma, etc.
Precocious puberty in boys (gonadotrophins LH or




Galactorrhoea (placental lactogen = somatomammo-
trophin)-gonadal and trophoblastic tumours.
. 10
MECHANISM
Why and how do cancer cells start producing hormones of
another tissue? It is believed that the DNA of all primitive
cell nuclei is totipotential-capable of producing any
natural polypeptide sequence-but that during tissue deve-
lopment this g~neralised genetic-biochemical information
is repressed by histones. so limiting the adult cell to just
doing its own thing. Malignant transformation, itself a
genetic abnormality, is imagined as de-repressing this infor-
mation, so allowing the cancer cell to synthesise other
proteins. On this theory the ectopically produced hormone
should be identical with the normal hormone, and indeed
this usually appears to be the case. Further, non-protein
hormone production would be unlikely since this would
require extremely massive de-repression in order for all
the required enzymes to be produced.
Another hypothesis suggests that regulation of the
genetic code is totally lost, the cancer cell fires away in all
directions, indiscriminately producing vast series of poly-
peptides, some of which, by laws of chance, have biologi-
cal consequences. This theory does not seem to fit with
the apparent tumour specificity, for instance in that the
bronchial squamous-cell carcinoma is associated with
hypercalcaemia, whereas the oat-cell tumour is responsible
for almost all other ectopic hormones.
One may wonder whether other peptides, at present
unknown, may cause some of the other systemic manifes-
tations of cancer-neurological, dermatological, haemato-
logical, skeletal, vascular, renal-the fever, anaemia and
even death.
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